WCLC 2025 - Posters & ePosters-P2.06.102 Prevalence and Concordance Analysis of MET Amplification/Overexpression in a Phase 1 Study of Davutamig (REGN5093) in a NSCLC

P2.06.102 Prevalence and Concordance Analysis of MET Amplification/Overexpression in a Phase 1 Study of Davutamig (REGN5093) in a NSCLC

Asset Subtitle

Dimple Modi

Meta Tag

Speaker Dimple Modi

Topic Pathology and Biomarkers